In hypoxic TNBC cells, HIF1α also drives lysyl oxidase (LOX) expression to regulate the tumor microenvironment via downstream integrin/FAK signaling and, as a result, confers resistance to chemotherapeutic agents. Here, LOX is linked to neoplasm.